4.7 Letter

Presence of the A226V mutation in autochthonous and imported Italian chikungunya virus strains

期刊

CLINICAL INFECTIOUS DISEASES
卷 47, 期 3, 页码 428-429

出版社

OXFORD UNIV PRESS INC
DOI: 10.1086/589925

关键词

-

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Infectious Diseases

Bacterial infections in critically ill patients with SARS-2-COVID-19 infection: results of a prospective observational multicenter study

Vincenzo De Santis, Alberto Corona, Domenico Vitale, Cecilia Nencini, Antonella Potalivo, Anna Prete, Gianluca Zani, Anna Malfatto, Luigi Tritapepe, Stefania Taddei, Alessandro Locatelli, Vittorio Sambri, Maurizio Fusari, Mervyn Singer

Summary: In critically ill patients infected with COVID-19, the incidence of bacterial infections is high and associated with worse outcomes. Regular microbiological surveillance and strict infection control measures are crucial.

INFECTION (2022)

Article Immunology

Humoral and T-Cell Immune Response After 3 Doses of Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Fragile Patients: The Italian VAX4FRAIL Study

Paolo Corradini, Chiara Agrati, Giovanni Apolone, Alberto Mantovani, Diana Giannarelli, Vincenzo Marasco, Veronica Bordoni, Alessandra Sacchi, Giulia Matusali, Carlo Salvarani, Pier Luigi Zinzani, Renato Mantegazza, Fabrizio Tagliavini, Maria Teresa Lupo-Stanghellini, Fabio Ciceri, Silvia Damian, Antonio Uccelli, Daniela Fenoglio, Nicola Silvestris, Fausto Baldanti, Giulia Piaggio, Gennaro Ciliberto, Aldo Morrone, Franco Locatelli, Valentina Sinno, Maria Rescigno, Massimo Costantini

Summary: This study investigated the immune response to the SARS-CoV-2 vaccine in patients with tumors and immune disorders. The results showed that immunosuppressive treatment was a risk factor for a low humoral response, while the booster dose improved both humoral and T-cell responses.

CLINICAL INFECTIOUS DISEASES (2023)

Article Multidisciplinary Sciences

Persistent Spike-specific T cell immunity despite antibody reduction after 3 months from SARS-CoV-2 BNT162b2-mRNA vaccine

Chiara Agrati, Concetta Castilletti, Delia Goletti, Alessandra Sacchi, Veronica Bordoni, Davide Mariotti, Stefania Notari, Giulia Matusali, Silvia Meschi, Linda Petrone, Alessandra Aiello, Saeid Najafi Fard, Chiara Farroni, Francesca Colavita, Daniele Lapa, Sara Leone, Alessandro Agresta, Maria Capobianchi, Giuseppe Ippolito, Francesco Vaia, Vincenzo Puro

Summary: This study aimed to evaluate the dynamics and persistence of immune response in Health Care Workers who received the BNT162b2-mRNA vaccine. The vaccine induced both humoral and cell-mediated immune response, with the cell-mediated response persisting longer. The study also found a correlation between cellular and humoral response, suggesting coordinated immunity.

SCIENTIFIC REPORTS (2022)

Article Immunology

Kinetics of the B- and T-Cell Immune Responses After 6 Months From SARS-CoV-2 mRNA Vaccination in Patients With Rheumatoid Arthritis

Chiara Farroni, Andrea Picchianti-Diamanti, Alessandra Aiello, Emanuele Nicastri, Bruno Lagana, Chiara Agrati, Concetta Castilletti, Silvia Meschi, Francesca Colavita, Gilda Cuzzi, Rita Casetti, Germana Grassi, Linda Petrone, Valentina Vanini, Andrea Salmi, Federica Repele, Anna Maria Gerarda Altera, Gaetano Maffongelli, Angela Corpolongo, Simonetta Salemi, Roberta Di Rosa, Gabriele Nalli, Giorgio Sesti, Francesco Vaia, Vincenzo Puro, Delia Goletti

Summary: This study assessed the kinetics of humoral and cell-mediated responses in rheumatoid arthritis patients treated with different immunosuppressive therapies after receiving SARS-CoV-2 vaccination. The results showed a reduction in antibody titers after 6 months, although they were still detectable in a majority of patients. B-cell and T-cell responses were also weakened.

FRONTIERS IN IMMUNOLOGY (2022)

Editorial Material Infectious Diseases

Polio is back? The risk of poliomyelitis recurrence globally, and the legacy of the severe acute respiratory syndrome coronavirus 2 pandemic

Concetta Castilletti, Maria Rosaria Capobianchi

CLINICAL MICROBIOLOGY AND INFECTION (2023)

Article Virology

Viral Population Heterogeneity and Fluctuating Mutational Pattern during a Persistent SARS-CoV-2 Infection in an Immunocompromised Patient

Martina Brandolini, Silvia Zannoli, Giulia Gatti, Valentina Arfilli, Monica Cricca, Giorgio Dirani, Agnese Denicolo, Simona Semprini, Laura Grumiro, Manuela Imola, Damiano Larne, Maria Michela Marino, Martina Manera, Andrea Mancini, Francesca Taddei, Manuel Zagarrigo, Carlo Biagetti, Vittorio Sambri

Summary: This study aims to provide further insight into the evolutionary dynamics of SARS-CoV-2 by analyzing a patient with follicular lymphoma who developed a persistent infection for over 7 months. The analysis revealed the evolution of genetically similar subpopulations within the host, indicating that prolonged replication is associated with intra-host virus evolution. These findings support the hypothesis that SARS-CoV-2 can undergo adaptive evolution in immunocompromised patients.

VIRUSES-BASEL (2023)

Review Oncology

Microbiota in the Natural History of Pancreatic Cancer: From Predisposition to Therapy

Cecilia Binda, Giulia Gibiino, Monica Sbrancia, Chiara Coluccio, Maria Cazzato, Lorenzo Carloni, Alessandro Cucchetti, Giorgio Ercolani, Vittorio Sambri, Carlo Fabbri

Summary: Pancreatic cancer still has a poor prognosis, despite advancements in diagnosis and surgical management. The gut microbiome is gaining interest in its role in the development and management of pancreatic cancer. This review aims to provide a comprehensive understanding of the gut microbiome's role in the history of pancreatic cancer for researchers and clinicians.

CANCERS (2023)

Article Microbiology

Omicron Sub-Lineage BA.5 and Recombinant XBB Evasion from Antibody Neutralisation in BNT162b2 Vaccine Recipients

Martina Brandolini, Giulia Gatti, Laura Grumiro, Silvia Zannoli, Valentina Arfilli, Monica Cricca, Giorgio Dirani, Agnese Denicolo, Maria Michela Marino, Martina Manera, Andrea Mancini, Francesca Taddei, Simona Semprini, Vittorio Sambri

Summary: The recent emergence of new SARS-CoV-2 variants resulting from recombination has raised concerns about enhanced infectivity and immune escape. XBB, a recombinant of BA.2.10 and BA.2.75, has rapidly increased in prevalence and showed enhanced immune escape ability compared to ancestral lineage and another co-circulating variant. This study highlights the importance of monitoring immune escape and reformulating vaccines for new and forthcoming variants.

MICROORGANISMS (2023)

Letter Infectious Diseases

People with asymptomatic or unrecognised infection potentially contribute to monkeypox virus transmission

Silvia Accordini, Maddalena Cordioli, Elena Pomari, Evelina Tacconelli, Concetta Castilletti

LANCET MICROBE (2023)

Article Biochemistry & Molecular Biology

Comparison of SARS-CoV-2 Detection in Nasopharyngeal Swab and Saliva Samples from Patients Infected with Omicron Variant

Licia Bordi, Giuseppe Sberna, Eleonora Lalle, Lavinia Fabeni, Valentina Mazzotta, Simone Lanini, Angela Corpolongo, Anna Rosa Garbuglia, Emanuele Nicastri, Enrico Girardi, Francesco Vaia, Andrea Antinori, Fabrizio Maggi

Summary: The study compared the detection of the SARS-CoV-2 Omicron variant in nasopharyngeal-swab (NPS) and oral saliva samples. Results showed good agreement between the two types of samples, with a significant correlation among cycle threshold values. The study also found that saliva can be used as an alternative specimen for the detection and follow-up of Omicron-infected patients.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Medicine, General & Internal

Subjects who developed SARS-CoV-2 specific IgM after vaccination show a longer humoral immunity and a lower frequency of infection

Chiara Piubelli, Alessandra Ruggiero, Lucia Calciano, Cristina Mazzi, Concetta Castilletti, Natalia Tiberti, Sara Caldrer, Matteo Verze, Silvia Stefania Longoni, Simone Accordini, Zeno Bisof, Donato Zipeto

Summary: The development of SARS-CoV-2-specific IgM after vaccination is associated with higher levels of SARS-CoV-2 neutralizing IgG. This study aims to assess whether IgM development is also associated with longer-lasting immunity. The results show that IgM development after vaccination is associated with higher levels of IgG antibodies in the short and long term, and most individuals who developed IgM antibodies did not experience infection, suggesting a lower risk of infection.

EBIOMEDICINE (2023)

Article Pharmacology & Pharmacy

An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro

Davide D'Angelo, Eride Quarta, Stefania Glieca, Giada Varacca, Lisa Flammini, Simona Bertoni, Martina Brandolini, Vittorio Sambri, Laura Grumiro, Giulia Gatti, Giorgio Dirani, Francesca Taddei, Annalisa Bianchera, Fabio Sonvico, Ruggero Bettini, Francesca Buttini

Summary: This study developed a dry inhalation powder of cyclosporine-A for lung transplantation rejection prevention and COVID-19 treatment. The impact of excipients on the powder's critical quality attributes was investigated. The optimized powder exhibited faster dissolution, better respirability, and showed efficacy in reducing IL-6 and inhibiting SARS-CoV-2 replication, suggesting its potential as a therapeutic strategy for lung rejection prevention and COVID-19 treatment.

PHARMACEUTICS (2023)

Article Medicine, General & Internal

Evaluation of a ddPCR Commercial Assay for the Absolute Quantification of the Monkeypox Virus West Africa in Clinical Samples

Elena Pomari, Antonio Mori, Silvia Accordini, Annalisa Donini, Maddalena Cordioli, Evelina Tacconelli, Concetta Castilletti

Summary: A commercial ddPCR assay was evaluated for the detection of the West African clade of monkeypox virus (MPXV) in clinical samples. The assay showed good performance for skin lesions and rectal swabs.

DIAGNOSTICS (2023)

Article Virology

Genomic and Temporal Analysis of Deletions Correlated to qRT-PCR Dropout in N Gene in Alpha, Delta and Omicron Variants

Giulia Gatti, Martina Brandolini, Andrea Mancini, Francesca Taddei, Silvia Zannoli, Giorgio Dirani, Martina Manera, Valentina Arfilli, Agnese Denicolo, Anna Marzucco, Maria Sofia Montanari, Irene Zaghi, Massimiliano Guerra, Rita Tennina, Maria Michela Marino, Laura Grumiro, Monica Cricca, Vittorio Sambri

Summary: Since the first SARS-CoV-2 outbreak, mutations have changed the viral genome sequence, structure, and protein folding, leading to the onset of new variants. These alterations challenge both the clinical field and diagnostic demand due to detection failures and incomplete PCR results. Analyzing understudied genes such as N and investigating regions prone to mutation through WG-NGS can help identify new or reacquired mutations for designing robust primers.

VIRUSES-BASEL (2023)

Article Immunology

Coordinated innate and T-cell immune responses in mild COVID-19 patients from household contacts of COVID-19 cases during the first pandemic wave

Alessandra Aiello, Adriano Grossi, Silvia Meschi, Marcello Meledandri, Valentina Vanini, Linda Petrone, Rita Casetti, Gilda Cuzzi, Andrea Salmi, Anna Maria Altera, Luca Pierelli, Gina Gualano, Tommaso Ascoli Bartoli, Concetta Castilletti, Chiara Agrati, Enrico Girardi, Fabrizio Palmieri, Emanuele Nicastri, Enrico Di Rosa, Delia Goletti

Summary: This study aimed to characterize the early immune responses to SARS-CoV-2 infection in household contacts of COVID-19 cases. The findings showed that plasmatic IFN-alpha and IFN-gamma T-cell specific response could appear early in the absence of seroconversion, and had a higher positivity rate compared to the serological response in individuals with positive swabs.

FRONTIERS IN IMMUNOLOGY (2022)

暂无数据